Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE8556.55149.95 (+1.78 %)
PREV CLOSE () 8406.60
OPEN PRICE () 8463.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 323
TODAY'S LOW / HIGH ()8420.00 8586.00
52 WK LOW / HIGH ()7630 9850
NSE8569.50136 (+1.61 %)
PREV CLOSE() 8433.50
OPEN PRICE () 8401.00
BID PRICE (QTY) 8569.50 (3)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6855
TODAY'S LOW / HIGH() 8385.50 8595.00
52 WK LOW / HIGH ()7551.5 9849.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1979

Management Info :

Shilpa Divekar Nirula - Chairman - Managing Director

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone : 080 6774 8000

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE
NEWS
12Jun AstraZeneca Pharma India informs about
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
11Jun AstraZeneca Pharma India informs about
AstraZeneca Pharma India has informed that on June 10, 2026, the company..
13Apr AstraZeneca Pharma gets nod to import,
AstraZeneca Pharma India has received permission from the Central Drugs..
13Apr AstraZeneca Pharma surges on getting n
Astrazeneca Pharma India is currently trading at Rs. 8172.85, up by 117...
17Mar AstraZeneca Pharma gets nod to import,
AstraZeneca Pharma India has received permission from the Central Drugs..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit448.81875.2
Gross Profit 581.4 2522
Operating Profit 668.62905.2
Net Sales 5786.122755.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Ajanta Pharma (BSE)
 3188.75 (4.12%)
M.Cap ( in Cr)
39838.85
Mankind Pharma (BSE)
 2537.05 (4.95%)
M.Cap ( in Cr)
104779.14
NGL Fine-Chem (BSE)
 3156.15 (2.67%)
M.Cap ( in Cr)
1949.88
Coral Laboratories (BSE)
 621.50 (13.11%)
M.Cap ( in Cr)
222.04
Cipla (BSE)
 1415.30 (4.54%)
M.Cap ( in Cr)
114334.35
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 16.44%
MUTUAL FUNDS/UTI 5.66%
FI/BANKS/INSURANCE 0.06%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77094.07291.17 (0.38%)
NIFTY24102.9089.80 (0.37%)
Dow Jones 51564.7072.15 (0.14%)
Nasdaq 26517.93496.27 (1.91%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI